About Obatala Sciences
Obatala Sciences is a company based in New Orleans (United States) founded in 2017 by Xiying Wu. Obatala Sciences has raised $3.54 million across 3 funding rounds from investors including Ochsner, HHS and Elevate Capital. The company has 10 employees as of January 31, 2021. Obatala Sciences offers products and services including ObaCell® ASC Fat-on-a-Chip Kit, ObaGel®, and Human Adipose-Derived Stem Cells. Obatala Sciences operates in a competitive market with competitors including BioLife Solutions, Emulate, CN Bio, RoosterBio and Shanghai Doning Biotechnology, among others.
- Headquarter New Orleans, United States
- Employees 10 as on 31 Jan, 2021
- Founders Xiying Wu
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Obatala Sciences, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.54 M (USD)
in 3 rounds
-
Latest Funding Round
$3 M (USD), Series A
Oct 13, 2022
-
Investors
Ochsner
& 6 more
-
Employee Count
10
as on Jan 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Obatala Sciences
Obatala Sciences offers a comprehensive portfolio of products and services, including ObaCell® ASC Fat-on-a-Chip Kit, ObaGel®, and Human Adipose-Derived Stem Cells.
Kit for modeling adipose tissue in pre-clinical drug development research.
Human-derived hydrogel for stem cell expansion and tissue engineering.
Stem cells for use in biomedical research and disease modeling.
People of Obatala Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of Obatala Sciences
Obatala Sciences has successfully raised a total of $3.54M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Obatala Sciences
Obatala Sciences has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Ochsner, HHS and Elevate Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on underserved entrepreneurs is provided.
|
Locked | Locked | Locked | |
|
Venture capital funding is provided by être Venture Capital.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Obatala Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Obatala Sciences
Investment portfolio details for Obatala Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Obatala Sciences
Detailed financials for Obatala Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Obatala Sciences Comparisons
Peer comparison for Obatala Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Obatala Sciences
Obatala Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioLife Solutions, Emulate, CN Bio, RoosterBio and Shanghai Doning Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| Locked | Locked | Locked |
Developer of in vitro models for drug development
|
|
| Locked | Locked | Locked |
Organ-on-a-chip platforms are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Developer of human mesenchymal stem cells and extracellular vesicles
|
|
| Locked | Locked | Locked |
Serum-free cell culture media is supplied to biopharmaceutical industries.
|
|
| Locked | Locked | Locked |
Neural exosome platform is developed for neurodegenerative disease therapeutics.
|
Detailed competitors of Obatala Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Obatala Sciences
Complete news archive for Obatala Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Obatala Sciences
Obatala Sciences was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Obatala Sciences is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
Trivia Frazier is the current CEO of Obatala Sciences.
Obatala Sciences is a funded company, having raised a total of $3.54M across 3 funding rounds to date.
As of Jan 31, 2021, the latest employee count at Obatala Sciences is 10.
Provider of research enabling products and services to research centers. The platform offers multiple services such as adipose tissue-derived stromal stem cells, human adult primary cell, 3D discovery tools such as ObaGel and ObaCell among others. The platform also offers medial and culture reagents such as OsteoQual.
Obatala Sciences's top competitors include Emulate, CN Bio and RoosterBio.
Obatala Sciences offers ObaCell® ASC Fat-on-a-Chip Kit, ObaGel®, and Human Adipose-Derived Stem Cells.
Obatala Sciences has 7 investors. Key investors include Ochsner, HHS, Elevate Capital, être Venture Capital, and Ochsner Lafayette General.